These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8828796)

  • 21. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 22. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
    Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
    Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intrinsic lysis concept.
    Gurewich V; Liu JN; Pannell R
    Ann N Y Acad Sci; 1992 Dec; 667():224-32. PubMed ID: 1309040
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):117-21. PubMed ID: 8457638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M; Lijnen HR; Van Hoef B; De Cock F; Collen D
    Eur J Biochem; 1989 Oct; 185(1):141-9. PubMed ID: 2530085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase-catalysed plasminogen activation. Effects of ligands binding to the AH-site of plasminogen.
    Christensen U
    Biochim Biophys Acta; 1988 Nov; 957(2):258-65. PubMed ID: 3191143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esterase A is a proteinase from rat urine that can activate plasminogen.
    Ryan TJ; Keegan MC; McMartin DN; Dickerman HW
    Biochim Biophys Acta; 1984 Jul; 800(1):87-95. PubMed ID: 6234943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
    Sun Z; Liu JN
    Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
    Wijngaards G; Rijken DC; van Wezel AL; Groeneveld E; van der Velden CA
    Thromb Res; 1986 Jun; 42(6):749-60. PubMed ID: 3088754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
    Gurewich V
    Enzyme; 1988; 40(2-3):97-108. PubMed ID: 2971533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.
    Chen W; Li Y; Chen P; Wu M; Wang L; Zhang H; Wang L
    J Thromb Thrombolysis; 2016 Jul; 42(1):118-26. PubMed ID: 26814674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN; Harpel PC; Pannell R; Gurewich V
    Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Jan; 162(2):351-6. PubMed ID: 3803392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.